These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16522556)

  • 1. How can even economists call addiction rational?
    Ferguson BS
    Subst Use Misuse; 2006; 41(4):423-6. PubMed ID: 16522556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A research agenda for economic evaluation of substance abuse services.
    French MT; Drummond M
    J Subst Abuse Treat; 2005 Sep; 29(2):125-37. PubMed ID: 16135341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health economics in public health.
    Ammerman AS; Farrelly MA; Cavallo DN; Ickes SB; Hoerger TJ
    Am J Prev Med; 2009 Mar; 36(3):273-5. PubMed ID: 19215853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severity.
    Chen S; Barnett PG; Sempel JM; Timko C
    J Subst Abuse Treat; 2006 Jul; 31(1):95-105. PubMed ID: 16814015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why we should still estimate the costs of substance abuse even if we needn't pay undue attention to the bottom line.
    Single E
    Drug Alcohol Rev; 2009 Mar; 28(2):117-21. PubMed ID: 19320695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic and other views of addiction: implications for the choice of alcohol, tobacco and drug policies.
    Buck D; Godfrey C; Sutton M
    Drug Alcohol Rev; 1996 Dec; 15(4):357-68. PubMed ID: 16203393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing.
    Miller TR; Zaloshnja E; Spicer RS
    Accid Anal Prev; 2007 May; 39(3):565-73. PubMed ID: 17125723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economics and drugs: promises, problems, and prospects.
    Harwood HJ
    NIDA Res Monogr; 1991; 113():46-56. PubMed ID: 1762642
    [No Abstract]   [Full Text] [Related]  

  • 11. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic modeling of the rational consumption of addictive substances.
    Ferguson BS
    Subst Use Misuse; 2006; 41(4):573-603. PubMed ID: 16522565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polydrug abuse in heroin addicts: a behavioral economic analysis.
    Glautier S
    Addiction; 1998 Apr; 93(4):603-4; discussion 605-6. PubMed ID: 9696618
    [No Abstract]   [Full Text] [Related]  

  • 14. A critical review of accounting and economic methods for estimating the costs of addiction treatment.
    Cartwright WS
    J Subst Abuse Treat; 2008 Apr; 34(3):302-10. PubMed ID: 17614244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does treatment 'pay for itself'? Looking at the economic argument for addiction treatment.
    Ettner SL
    Behav Healthc; 2006 May; 26(5):32-4. PubMed ID: 16736917
    [No Abstract]   [Full Text] [Related]  

  • 16. Linking economics and risk assessment.
    Dockins C; Griffiths CW; Owens N; Simon NB; Axelrad DA
    J Toxicol Environ Health A; 2004 Apr 23-May 28; 67(8-10):611-20. PubMed ID: 15192857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding multiple substance misuse: an alternative view from behavioral economics.
    Tucker JA
    Addiction; 2001 May; 96(5):776-7. PubMed ID: 11370643
    [No Abstract]   [Full Text] [Related]  

  • 18. The economic shaping of substance abuse.
    Lerner WD; Raczynski JM
    NIDA Res Monogr; 1988; 84():62-73. PubMed ID: 3147386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of relapse prevention for substance users: treatment settings and health care policy.
    Yamada T; Chen CC; Yamada T
    Adv Health Econ Health Serv Res; 2005; 16():431-50. PubMed ID: 17867251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.
    Vijgen SM; van Baal PH; Hoogenveen RT; de Wit GA; Feenstra TL
    Health Educ Res; 2008 Apr; 23(2):310-8. PubMed ID: 17675649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.